Screening, Diagnosis, and Staging of Cervical Cancer

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 31-45

  Chan, Y M ^a,b   Luesley, David M ^c,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 19544384506     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50006-3     Document Type: Chapter

References (201)

1. J Ferlay, DM Parkin and P Pisani (1998) GLOBOCAN: Cancer Incidence and Mortality Worldwide. IARC Cancer Base 3 Lyons, France: International Agency for Research on Cancer
2. DM Parkin, P Pisani and J Ferlay (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 827-841.
3. P Sasieni and J Adams (1999) Effect of screening on cervical cancer mortality in England and Wales: Analysis of trends with an age period cohort model. BMJ 318 1244-1245.
4. M Quinn, P Babb, J Jones, et al. (1999) Effect of screening on incidence of and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics. BMJ 318 904-908.
5. A Anttila, E Pukkala, B Soderman, et al. (1999) Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence. Int J Cancer 83 59-65.
6. N Aristizabal, C Cuello, P Correa, et al. (1984) The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer 34 5-9.
7. EA Clarke and TW Anderson (1979) Does screening by “Pap” smears help prevent cervical cancer? A case-control study. Lancet 2 1-4.
8. V Wangsuphachart, DB Thomas, A Koetsawang, et al. (1987) Risk factors for invasive cervical cancer and reduction of risk by “Pap” smears in Thai women. Int J Epidemiol 16 362-366.
9. ZF Zhang, DM Parkin, SZ Yu, et al. (1989) Risk factors for cancer of the cervix in a rural Chinese population. Int J Cancer 43 762-767.
10. AB Miller (1986) Evaluation of the impact of screening for cancer of the cervix. M Hakama, AB Miller, NE Day (Eds) Screening for Cancer of the Uterine Cervix Lyons, France: International Agency for Research on Cancer 149-160.
11. WM Christopherson, FE Lundin Jr, WM Mendez, et al. (1976) Cervical cancer control: A study of morbidity and mortality trends over a twenty-one-year period. Cancer 38 1357-1366.
12. DA Boyes (1981) The value of a Pap smear program and suggestions for its implementation. Cancer 48(2 Suppl), 613-621.
13. AB Miller, J Lindsay and GB Hill (1976) Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 17 602-612.
14. G Johannesson, G Geirsson and N Day (1978) The effect of mass screening in Iceland, 1965-1974, on the incidence and mortality of cervical carcinoma. Int J Cancer 21 418-425.
15. G Geirsson (1986) Organization of screening in technically advanced countries: Iceland. M Hakama, AB Miller, NE Day (Eds) Screening for Cancer of the Uterine Cervix Lyons, France: International Agency for Research on Cancer 239-250.
16. AP Vizcaino, V Moreno, FX Bosch, et al. (2000) International trends in incidence of cervical cancer. II. Squamous-cell carcinoma. Int J Cancer 86 429-435.
17. F Levi, F Lucchini, E Negri, et al. (2000) Cervical cancer mortality in young women in Europe: Patterns and trends. Eur J Cancer 36 2266-2271.
18. IRAC Working Group on Cervical Cancer Screening (1986) Summary chapter. M Hakama, AB Miller, NE Day (Eds) Screening for Cancer of the Uterine Cervix Lyons, France: International Agency for Research on Cancer 133-142.
19. E Laara, NE Day and M Hakama (1987) Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1 1247-1249.
20. IRAC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: The duration of low risk after negative result of cervical cytology and its implication for screening policies. BMJ 293 659-664.
21. M Hakama and K Louhivuori (1988) A screening programme for cervical cancer that worked. Cancer Surv 7 403-416.
22. PD Sasieni, J Cuzick and E Lynch-Farmery (1996) Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer 73 1001-1005.
23. B Rodu and P Cole (2001) The fifty-year decline of cancer in America. J Clin Oncol 19 239-241.
24. M Hakama, J Chamberlain, NE Day, et al. (1985) Evaluation of screening programmes for gynaecological cancer. Br J Cancer 52 669-673.
25. AB Miller, J Chamberlain, NE Day, et al. (1990) Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer. Int J Cancer 46 761-769.
26. AB Miller (1992) Cervical cancer screening programmes: Managerial guidelines Geneva: World Health Organization
27. K Sigurdsson (1999) The Icelandic and Nordic cervical screening programs: Trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 78 478-485.
28. J Ponten, HO Adami, R Bergstrom, et al. (1995) Strategies for global control of cervical cancer. Int J Cancer 60 1-26.
29. A Linos and E Riza (2000) Comparisons of cervical cancer screening programmes in the European Union. Eur J Cancer 36 2260-2265.
30. DM Parkin, X Nguyen-Dinh and NE Day (1985) The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 92 150-157.
31. J Patnick (1997) Has screening for cervical cancer been successful? Br J Obstet Gynaecol 104 876-878.
32. L Gibson, DJ Spiegelhalter, C Camilleri-Ferrante, et al. (1997) Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993. J Med Screen 4 44-48.
33. DM Luesley, J Cullimore, CW Redman, et al. (1990) Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ 300 1690-1693.
34. RH Hammond and DK Edmonds (1990) Does treatment for cervical intraepithelial neoplasia affect fertility and pregnancy? BMJ 301 1344-1345.
35. J Mandelblatt, I Gopaul and M Wistreich (1986) Gynecological care of elderly women: Another look at Papanicolaou smear testing. JAMA 256 367-371.
36. A Fletcher (1990) Screening for cancer of the cervix in elderly women. Lancet 335 97-99.
37. MC Fahs, J Mandelblatt, C Schechter, et al. (1992) Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med 117 520-527.
38. TW McDonald, JJ Neutens, LM Fischer, et al. (1989) Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteem and body image. Gynecol Oncol 34 345-349.
39. TM Marteau, P Walker, J Giles, et al. (1990) Anxieties in women undergoing colposcopy. Br J Obstet Gynaecol 97 859-861.
40. AM Barsevick and D Lauver (1990) Women's informational needs about colposcopy. Image J Nurs Sch 22 23-26.
41. S Bell, M Porter, H Kitchener, et al. (1995) Psychological response to cervical screening. Prev Med 24 610-616.
42. F Fylan (1998) Screening for cervical cancer: A review of women's attitudes, knowledge, and behaviour. Br J Gen Pract 48 1509-1514.
43. MT Fahey, L Irwig and P Macaskill (1995) Meta-analysis of Pap test accuracy. Am J Epidemiol 141 680-689.
44. JE Macgregor, MK Campbell, EM Mann, et al. (1994) Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 308 1407-1411.
45. LG Koss (1989) Cytology: Accuracy of diagnosis. Cancer 64(1 Suppl), 249-252.
46. LG Koss (1993) Cervical (Pap) smear: New directions. Cancer 71(4 Suppl), 1406-1412.
47. R Reid, MD Greenberg, A Lorincz, et al. (1991) Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 164 1461-1471.
48. DN Slater, PC Milner and H Radley (1994) Audit of deaths from cervical cancer: Proposal for an essential component of the National Screening Program. J Clin Pathol 47 27-28.
49. DA Boyes, B Morrison, EG Knox, et al. (1982) A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 5 1-29.
50. S Liu, R Semenciw, A Probert, et al. (2001) Cervical cancer in Canada: Changing patterns in incidence and mortality. Int J Gynecol Cancer 11 24-31.
51. AP Vizcaino, V Moreno, FX Bosch, et al. (1998) International trends in the incidence of cervical cancer. I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75 536-545.
52. K Sigurdsson (1995) Quality assurance in cervical cancer screening: The Icelandic experience 1964-1993. Eur J Cancer 31A 728-734.
53. H Mitchell, G Medley, I Gordon, et al. (1995) Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: No strong evidence of benefit. Br J Cancer 71 894-897.
54. D Solomon, D Davey, R Kurman, et al. (2002) The Bethesda 2001 Workshop. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287 2114-2119.
55. ME Sherman, MH Schiffman, AT Lorincz, et al. (1994) Toward objective quality assurance in cervical cytopathology: Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 102 182-187.
56. MM Manos, WK Kinney, LB Hurley, et al. (1999) Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281 1605-1610.
57. MG Joseph, F Cragg, VC Wright, et al. (1991) Cyto-histological correlates in a colposcopic clinic: A 1-year prospective study. Diagn Cytopathol 7 477-481.
58. MC Boscha, PEM Rietweld-Scheffers and ME Boon (1992) Characteristics of false negative smears in the normal screening population. Acta Cytol 36 711-716.
59. ME Sherman and D Kelly (1992) High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: Screening failures or rapid progression? Mod Pathol 5 337-342.
60. KR Lee, R Ashfaq, GG Birdsong, et al. (1997) Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 90 278-284.
61. ME Sherman, M Mendoza, KR Lee, et al. (1998) Performance of liquid-based, thin-layer cervical cytology: Correlation with reference diagnoses and human papillomavirus testing. Mod Pathol 11 837-843.
62. JM Roberts, AM Gurley, JK Thurloe, et al. (1997) Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear. Med J Aust 167 466-469.
63. JL Papillo, MA Zarka and TL St John (1998) Evaluation of the ThinPrep Pap test in clinical practice: A seven-month, 16,314-case experience in northern Vermont. Acta Cytol 42 203-208.
64. DR Bolick and DJ Hellman (1998) Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system. Acta Cytol 42 209-213.
65. J Linder and D Zahniser (1998) ThinPrep Papanicolaou testing to reduce false-negative cervical cytology. Arch Pathol Lab Med 122 139-144.
66. ML Hutchinson, DJ Zahniser, ME Sherman, et al. (1999) Utility of liquid-based cytology for cervical carcinoma screening: Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 87 48-55.
67. ER Myers, DC McCrory, S Subramanian, et al. (2000) Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening. Obstet Gynecol 96 645-652.
68. TC Wright Jr, JT Cox, LS Massad, et al. (2002) ASCCP-Sponsored Consensus Conference: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287 2120-2129.
69. MH Stoler (2002) New Bethesda terminology and evidence-based management guidelines for cervical cytology findings. JAMA 287 2140-2141.
70. JM Walboomers, MV Jacobs, MM Manos, et al. (1999) Human papillo-mavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 12-19.
71. A Giannoudis and CS Herrington (2001) Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193 295-302.
72. FX Bosch, A Lorincz, N Munoz, et al. (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 244-265.
73. FX Bosch, MM Manos, N Munoz, et al. (1995) Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87 796-802.
74. L Rozendaal, JM Walboomers, JC van der Linden, et al. (1996) PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68 766-769.
75. AJ Remmink, JM Walboomers, TJ Helmerhorst, et al. (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer 61 306-311.
76. GY Ho, RD Burk, S Klein, et al. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87 1365-1371.
77. MA Nobbenhuis, JM Walboomers, TJ Helmerhorst, et al. (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study. Lancet 354 20-25.
78. FX Bosch, T Rohan, A Schneider, et al. (2001) Papillomavirus research update: Highlights of the Barcelona HPV 2000 International Papillomavirus Conference. J Clin Pathol 54 163-175.
79. GY Ho, R Bierman, L Beardsley, et al. (1998) Natural history of cervico-vaginal papillomavirus infection in young women. N Engl J Med 338 423-428.
80. LA Koutsky, KK Holmes, CW Critchlow, et al. (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327 1272-1278.
81. GD Zielinski, PJ Snijders, L Rozendaal, et al. (2001) HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears. Br J Cancer 85 398-404.
82. MA Nobbenhuis, TJ Helmerhorst, AJ van den Brule, et al. (2001) Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358 1782-1783.
83. H zur Hausen (2000) Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92 690-698.
84. MH Schiffman, NB Kiviat, RD Burk, et al. (1995) Accuracy and inter-laboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 33 545-550.
85. CL Peyton, M Schiffman, AT Lorincz, et al. (1998) Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36 3248-3254.
86. T Sasagawa, Y Minemoto, W Basha, et al. (2000) A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV). Virus Res 67 127-139.
87. HU Bernard, SY Chan, MM Manos, et al. (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170 1077-1085.
88. C Clavel, M Masure, JP Bory, et al. (1999) Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1518 women. Br J Cancer 80 1306-1311.
89. M Schiffman, R Herrero, A Hildesheim, et al. (2000) HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. JAMA 283 87-93.
90. TC Wright Jr, L Denny, L Kuhn, et al. (2000) HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283 81-86.
91. J Cuzick, P Sasieni, P Davies, et al. (2000) A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 83 561-565.
92. J Cuzick, E Beverley, L Ho, et al. (1999) HPV testing in primary screening of older women. Br J Cancer 81 554-558.
93. I Nindl, A Lorincz, I Mielzynska, et al. (1998) Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 10 49-56.
94. DG Ferris, TC Wright Jr, MS Litaker, et al. (1998) Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract 46 136-141.
95. J Cuzick (2000) Human papillomavirus testing for primary cervical cancer screening. JAMA 283 108-109.
96. JT Cox, AT Lorincz, MH Schiffman, et al. (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172 946-954.
97. P Vassilakos, F de Marval, M Munoz, et al. (1998) Human papillomavirus (HPV) DNA assay as an adjunct to liquid-based Pap test in the diagnostic triage of women with an abnormal Pap smear. Int J Gynaecol Obstet 61 45-50.
98. G Fait, Y Daniel, MJ Kupferminc, et al. (1998) Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities? Gynecol Oncol 70 319-322.
99. BM Ronnett, MM Manos, JE Ransley, et al. (1999) Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 30 816-825.
100. D Solomon, M Schiffman and R Tarone ALTS Study group (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 93 293-299.
101. JC Shlay, T Dunn, T Byers, et al. (2000) Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears. Obstet Gynecol 96 410-416.
102. Shah, PM Howley (1996) Papillomavirus. BN Fields, DM Knipe, PM Howley, et al., (Eds) Virology Philadelphia: Lippincott-Raven 2077-2109.
103. E Megevand, L Denny, K Dehaeck, et al. (1996) Acetic acid visualization of the cervix: An alternative to cytologic screening. Obstet Gynecol 88 383-386.
104. R Sankaranarayanan, R Wesley, T Somanathan, et al. (1998) Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 83 2150-2156.
105. R Sankaranarayanan, B Shyamalakumary, R Wesley, et al. (1999) Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer 80 161-163.
106. University of Zimbabwe/JHPIEGO Cervical Cancer Project (1999) Visual inspection with acetic acid for cervical-cancer screening: Test qualities in a primary-care setting. Lancet 353 869-873.
107. L Denny, L Kuhn, A Pollack, et al. (2000) Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 89 826-833.
108. L Denny, L Kuhn, L Risi, et al. (2000) Two-stage cervical cancer screening: An alternative for resource-poor settings. Am J Obstet Gynecol 183 383-388.
109. L Denny, L Kuhn, A Pollack, et al. (2002) Direct visual inspection for cervical cancer screening: An analysis of factors influencing test performance. Cancer 94 1699-1707.
110. SJ Goldie, L Kuhn, L Denny, et al. (2001) Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness. JAMA 285 3107-3115.
111. EJ Suba and SS Raab (2001) Cervical cancer screening in developing countries. JAMA 286 3079-3081.
112. A Stafl (1981) Cervicography: A new method for cervical cancer detection. Am J Obstet Gynecol 139 815-825.
113. VI Kesic, WP Soutter, V Sulovic, et al. (1993) A comparison of cytology and cervicography in cervical screening. Int J Gynecol Cancer 3 395-398.
114. DG Ferris, MS Macfee, JA Miller, et al. (2002) The efficacy of telecolposcopy compared with traditional colposcopy. Obstet Gynecol 99 248-254.
115. DM Harper, MM Moncur, WH Harper, et al. (2000) The technical performance and clinical feasibility of telecolposcopy. J Fam Pract 49 623-627.
116. M Maiman, RG Fruchter, M Clark, et al. (1997) Cervical cancer as an AIDS-defining illness. Obstet Gynecol 89 76-80.
117. D Serraino, P Carrieri, C Pradier, et al. (1999) Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 82 334-337.
118. M Maiman, RG Fruchter, E Serur, et al. (1990) Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 38 377-382.
119. M Maiman, RG Fruchter, L Guy, et al. (1993) Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 71 402-406.
120. M Boccalon, U Tirelli, F Sopracordevole, et al. (1996) Intra-epithelial and invasive cervical neoplasia during HIV infection. Eur J Cancer 32A 2212-2217.
121. RG Fruchter, M Maiman, CD Arrastia, et al. (1998) Is HIV infection a risk factor for advanced cervical cancer? J Acquir Immune Defic Syndr Hum Retrovirol 18 241-245.
122. A Schaafer, W Friedmann, M Mielke, et al. (1991) The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 164 593-599.
123. I Heard, D Jeannel, C Bergeron, et al. (1997) Lack of behavioural risk factors for squamous intraepithelial lesions (SIL) in HIV-infected women. Int J STD AIDS 8 388-392.
124. M Maiman, RG Fruchter, A Sedlis, et al. (1998) Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 68 233-239.
125. LS Massad, KA Riester, KM Anastos, et al. (1999) Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 21 33-41.
126. G Cappiello, AR Garbuglia, R Salvi, et al. (1997) HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: An analysis of HPV genotypes. DIANAIDS Collaborative Study Group. Int J Cancer 72 982-986.
127. TC Wright Jr, J Koulos, F Schnoll, et al. (1994) Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: Outcome after loop electrosurgical excision. Gynecol Oncol 55 253-258.
128. K Holcomb, RP Matthews, JE Chapman, et al. (1999) The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women. Gynecol Oncol 74 428-431.
129. G La Ruche, V Leroy, I Mensah-Ado, et al. (1999) Short-term follow-up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa. Int J STD AIDS 10 363-368.
130. RG Fruchter, M Maiman, FH Sillman, et al. (1994) Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 171 531-537.
131. M Maiman, RG Fruchter, E Serur, et al. (1993) Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 82 170-174.
132. TV Ellerbrock, MA Chiasson, TJ Bush, et al. (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283 1031-1037.
133. M Maiman, RG Fruchter, A Sedlis, et al. (1998) Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 68 233-239.
134. CW Critchlow and NB Kiviat (1999) Old and new issues in cervical cancer control. J Natl Cancer Inst 91 200-201.
135. A Spinillo, E Capuzzo, P Tenti, et al. (1998) Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women. Gynecol Oncol 69 109-113.
136. TC Wright Jr, TV Ellerbrock, MA Chiasson, et al. (1994) Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: Prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol 84 591-597.
137. K Holcomb, O Abulafia, RP Matthews, et al. (1999) The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol 75 118-121.
138. TC Wright Jr, RD Moscarelli, P Dole, et al. (1996) Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 87 515-519.
139. G Del Priore, T Maag, M Bhattacharya, et al. (1995) The value of cervical cytology in HIV-infected women. Gynecol Oncol 56 395-398.
140. G La Ruche, I Mensah-Ado, C Bergeron, et al. (1999) Cervical screening in Africa: Discordant diagnosis in a double independent reading. DYSCER-CI Group. J Clin Epidemiol 52 953-958.
141. G Del Priore, PR Gilmore, T Maag, et al. (1996) Colposcopic biopsies versus loop electrosurgical excision procedure cone histology in human immunodeficiency virus-positive women. J Reprod Med 41 653-657.
142. S Cuthill, M Maiman, RG Fruchter, et al. (1995) Complications after treatment of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. J Reprod Med 40 823-828.
143. Centers for Disease Control and Prevention (1993) Sexually transmitted disease guidelines. MMWR Morb Mortal Wkly Rep 42(RR14), 90-91.
144. PG Walker (1995) CIN in pregnancy. DM Luesley, J Jordan, RM Richart (Eds) Intraepithelial neoplasia of the lower genital tract New York: Churchill Livingstone 221-229.
145. A Singer (1989) Malignancy and premalignancy of the genital tract in pregnancy. A Turnbull, G Chamberlain (Eds) Obstetrics Edinburgh: Churchill Livingstone 657-672.
146. BC Huff (2000) Abnormal cervical cytology in pregnancy: A laboratory and clinical dermatologic perspective. J Perinat Neonatal Nurs 14 52-62.
147. M Ueki, M Ueda, K Kumagai, et al. (1995) Cervical cytology and conservative management of cervical neoplasias during pregnancy. Int J Gynecol Pathol 14 63-69.
148. DC Chhieng, P Elgert, JF Cangiarella, et al. (2001) Significance of AGUS Pap smears in pregnant and postpartum women. Acta Cytol 45 294-299.
149. PF Kaminski, DS Lyon, JI Sorosky, et al. (1992) Significance of atypical cervical cytology in pregnancy. Am J Perinatol 9 340-343.
150. JP Connor (1998) Noninvasive cervical cancer complicating pregnancy. Obstet Gynecol Clin North Am 25 331-342.
151. JL Benedet, PA Selke and KG Nickerson (1987) Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy. Am J Obstet Gynecol 157 932-937.
152. C Palle, S Bangsboll and B Andreasson (2000) Cervical intraepithelial neoplasia in pregnancy. Acta Obstet Gynecol Scand 79 306-310.
153. K Economos, N Perez Veridiano, I Delke, et al. (1993) Abnormal cervical cytology in pregnancy: A 17-year experience. Obstet Gynecol 81 915-918.
154. A Mitsuhashi and S Sekiya (2000) Loop electrosurgical excision procedure (LEEP) during first trimester of pregnancy. Int J Gynaecol Obstet 71 237-239.
155. RM Richart and BA Barron (1969) A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 105 386-393.
156. AG Ostor (1993) Natural history of cervical intraepithelial neoplasia: A critical review. Int J Gynecol Pathol 12 186-192.
157. J Melnikow, J Nuovo, AR Willan, et al. (1998) Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 92 727-735.
158. KG Keijser, P Kenemans, PH van der Zanden, et al. (1992) Diathermy loop excision in the management of cervical intraepithelial neoplasia: Diagnosis and treatment in one procedure. Am J Obstet Gynecol 166 1281-1287.
159. MA Bigrigg, BW Codling, P Pearson, et al. (1990) Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit: Experience of low-voltage diathermy loop in 1000 patients. Lancet 336 229-231.
160. A Ferenczy (1995) Management of patients with high grade squamous intraepithelial lesions. Cancer 76(10 Suppl), 1928-1933.
161. CH Holschneider, K Ghosh and FJ Montz (1999) See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: A resource utilization analysis. Obstet Gynecol 94 377-385.
162. P Byrne, J Jordan, D Williams, et al. (1988) Importance of negative result of cervical biopsy directed by colposcopy. BMJ 296 172.
163. M Skehan, WP Soutter, K Lim, et al. (1990) Reliability of colposcopy and directed punch biopsy. Br J Obstet Gynaecol 97 811-816.
164. D Howe (1992) Colposcopically directed punch biopsy: A potentially misleading investigation. Br J Obstet Gynaecol 99 862.
165. DT Howe and AC Vincenti (1991) Is large loop excision of the transformation zone (LLETZ) more accurate than colposcopically directed punch biopsy in the diagnosis of cervical intraepithelial neoplasia? Br J Obstet Gynaecol 98 588-591.
166. NF Hacker (1988) Clinical and operative staging of cervical cancer. Baillieres Clin Obstet Gynaecol 2 747-759.
167. JM Heaps and JS Berek (1990) Surgical staging of cervical cancer. Clin Obstet Gynecol 33 852-862.
168. J Vidaurreta, A Bermudez, G di Paola, et al. (1999) Laparoscopic staging in locally advanced cervical carcinoma: A new possible philosophy? Gynecol Oncol 75 366-371.
169. LD Lagasse, WT Creasman, HM Shingleton, et al. (1980) Results and complications of operative staging in cervical cancer: Experience of the Gynecology Oncology Group. Gynecol Oncol 9 90-98.
170. JP LaPolla, JB Schlaerth, O Gaddis, et al. (1986) The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 24 194-199.
171. T Inoue and K Morita (1990) The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 65 1923-1927.
172. CK Chung, WA Nahhas, JA Stryker, et al. (1980) Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am J Obstet Gynecol 138 550-556.
173. RJ Chen, DY Chang, ML Yen, et al. (1998) Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 69 157-164.
174. CH Lai, JH Hong, S Hsueh, et al. (1999) Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: An analysis of 891 cases. Cancer 85 1537-1546.
175. H Ishikawa, T Nakanishi, T Inoue, et al. (1999) Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 73 42-46.
176. CA Perez, RJ Kurman, FB Stehman, et al. (1992) Uterine cervix. WJ Hoskins, CA Perez, RC Young (Eds) Principles and Practice of Gynecologic Oncology Philadelphia: JB Lippincott 591-662.
177. DF Dargent (1993) Laparoscopic surgery and gynecologic cancer. Curr Opin Obstet Gynecol 5 294-300.
178. DF Dargent (2001) Laparoscopic surgery in gynecologic oncology. Surg Clin North Am 81 949-964.
179. KK Chu, SD Chang, FP Chen, et al. (1997) Laparoscopic surgical staging in cervical cancer: Preliminary experience among Chinese. Gynecol Oncol 64 49-53.
180. JM Childers, K Hatch and EA Surwit (1992) The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecol Oncol 47 38-43.
181. NM Spirtos, JB Schlaerth, TW Spirtos, et al. (1995) Laparoscopic bilateral pelvic and paraaortic lymph node sampling: An evolving technique. Am J Obstet Gynecol 173 105-111.
182. M Possover, N Krause, R Kuhne-Heid, et al. (1998) Value of laparoscopic evaluation of paraaortic and pelvic lymph nodes for treatment of cervical cancer. Am J Obstet Gynecol 178 806-810.
183. JA Cosin, JM Fowler, MD Chen, et al. (1998) Pretreatment surgical staging of patients with cervical carcinoma: The case for lymph node debulking. Cancer 82 2241-2248.
184. WK Kinney, DO Hodge, EV Egorshin, et al. (1995) Surgical treatment of patients with stages IB and IIA carcinoma of the cervix and palpably positive pelvic lymph nodes. Gynecol Oncol 57 145-149.
185. BA Fine, RE Hempling, MS Piver, et al. (1995) Severe radiation morbidity in carcinoma of the cervix: Impact of pretherapy surgical staging and previous surgery. Int J Radiat Oncol Biol Phys 31 717-723.
186. NF Hacker, GV Wain and JL Nicklin (1995) Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5 250-256.
187. BA Goff, HG Muntz, PJ Paley, et al. (1999) Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 74 436-442.
188. A Hasenburg, JK Salama, TJ Van, et al. (2002) Evaluation of patients after extraperitoneal lymph node dissection and subsequent radiotherapy for cervical cancer. Gynecol Oncol 84 321-326.
189. R Vercamer, J Janssens, R Usewils, et al. (1987) Computed tomography and lymphography in the presurgical staging of early carcinoma of the uterine cervix. Cancer 60 1745-1750.
190. JM van Engelshoven, CW Versteege, JH Ruys, et al. (1984) Computed tomography in staging untreated patients with cervical cancer. Gynecol Obstet Invest 18 289-295.
191. NO Whitley, DE Brenner, A Francis, et al. (1982) Computed tomographic evaluation of carcinoma of the cervix. Radiology 142 439-446.
192. K Togashi, K Nishimura, T Sagoh, et al. (1989) Carcinoma of the cervix: Staging with MR imaging. Radiology 171 245-251.
193. PW Grigsby, BA Siegel and F Dehdashti (2001) Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19 3745-3749.
194. IG Kerr, MF Manji, J Powe, et al. (2001) Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: A retrospective review. Gynecol Oncol 81 477-480.
195. K Narayan, RJ Hicks, T Jobling, et al. (2001) A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: Potential impact on treatment. Int J Gynecol Cancer 11 263-271.
196. MJ Reinhardt, C Ehritt-Braun, D Vogelgesang, et al. (2001) Metastatic lymph nodes in patients with cervical cancer: Detection with MR imaging and FDG PET. Radiology 218 776-782.
197. PG Rose, LP Adler, M Rodriguez, et al. (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol 17 41-45.
198. PO Van Trappen, VG Gyselman, DG Lowe, et al. (2001) Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 357 15-20.
199. L Holmgren, MS O'Reilly and J Folkman (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1 149-153.
200. KJ Luzzi, IC MacDonald, EE Schmidt, et al. (1998) Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153 865-873.
201. N Cifuentes and JW Pickren (1979) Metastases from carcinoma of mammary gland: An autopsy study. J Surg Oncol 11 193-205.